Joining a clinical trial for cervical cancer opens the door to new treatments that could have life-changing effects.

Cervical cancer is a major health issue for Indian women, primarily caused by HPV. Key symptoms include abnormal bleeding and pelvic pain. Preventive measures such as HPV vaccination, safe sex, and ...

Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.

Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study ASCO Guidelines provide recommendations with ...